Dimensional Fund Advisors LP Has $181.35 Million Stock Holdings in Plexus Corp. $PLXS

Key Points

• Dimensional Fund Advisors LP reduced its holdings in Plexus Corp. by 8.4%, owning about 5.22% of the company's shares after selling 129,685 shares in the first quarter.
• In the first quarter, several other institutional investors made significant movements, with GAMMA Investing LLC increasing its position by 19,069.1%, now holding 170,797 shares valued at approximately $21.88 million.
• Plexus reported earnings of $1.90 per share, exceeding estimates, with a net margin of 4.04% and revenue growth of 6.0% year-over-year.

Dimensional Fund Advisors LP reduced its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 8.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,415,376 shares of the technology company's stock after selling 129,685 shares during the period. Dimensional Fund Advisors LP owned 5.22% of Plexus worth $181,348,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Nuveen Asset Management LLC boosted its position in shares of Plexus by 6.6% during the fourth quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock worth $55,012,000 after buying an additional 21,911 shares during the period. Northern Trust Corp raised its position in Plexus by 10.0% in the 4th quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock valued at $51,967,000 after purchasing an additional 30,163 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Plexus by 66.1% during the first quarter. Invesco Ltd. now owns 211,741 shares of the technology company's stock worth $27,130,000 after buying an additional 84,249 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of Plexus by 8.3% during the first quarter. Victory Capital Management Inc. now owns 185,200 shares of the technology company's stock worth $23,730,000 after purchasing an additional 14,267 shares during the last quarter. Finally, Nuveen LLC acquired a new position in Plexus in the 1st quarter valued at $22,975,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded up $6.71 during midday trading on Friday, hitting $137.26. The company's stock had a trading volume of 151,618 shares, compared to its average volume of 180,705. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $172.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. The stock has a market capitalization of $3.70 billion, a price-to-earnings ratio of 23.38 and a beta of 0.80. The stock's 50 day simple moving average is $132.44 and its 200 day simple moving average is $130.15.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.19. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.Plexus's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.

Insider Buying and Selling at Plexus

In related news, insider Michael J. Running sold 646 shares of the firm's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $130.05, for a total transaction of $84,012.30. Following the completion of the sale, the insider directly owned 630 shares of the company's stock, valued at $81,931.50. This trade represents a 50.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Oliver K. Mihm sold 2,102 shares of the company's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the transaction, the chief operating officer owned 21,155 shares in the company, valued at approximately $2,759,246.65. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold 12,484 shares of company stock worth $1,626,335 over the last 90 days. Company insiders own 1.76% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on PLXS shares. Wall Street Zen downgraded Plexus from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 16th. Needham & Company LLC decreased their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Stifel Nicolaus set a $140.00 price objective on Plexus in a report on Thursday, July 24th. Sidoti raised Plexus from a "neutral" rating to a "buy" rating and raised their price target for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Finally, Benchmark reiterated a "buy" rating and issued a $160.00 target price on shares of Plexus in a research report on Wednesday, June 4th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.